Immunic Reports Positive Long-Term Safety, Tolerability Data for Vidofludimus Calcium in MS Trial
Immunic Inc. (NASDAQ:IMUX) is one of the best penny stocks under $1 to buy now. On June 24, Immunic reported positive long-term open-label extension/OLE data from its Phase 2 EMPhASIS trial.